Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Recall immune memory: a new tool for generating late onset autoimmune myasthenia gravis.

Stacy S, Infante AJ, Wall KA, Krolick K, Kraig E.

Mech Ageing Dev. 2003 Aug-Sep;124(8-9):931-40.

PMID:
14499498
2.

Split tolerance in a novel transgenic model of autoimmune myasthenia gravis.

Stacy S, Gelb BE, Koop BA, Windle JJ, Wall KA, Krolick KA, Infante AJ, Kraig E.

J Immunol. 2002 Dec 1;169(11):6570-9.

3.
4.

CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis.

Milani M, Ostlie N, Wu H, Wang W, Conti-Fine BM.

J Neuroimmunol. 2006 Oct;179(1-2):152-62. Epub 2006 Aug 30.

PMID:
16945426
5.

T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor.

Lobito AA, Yang B, Lopes MF, Miagkov A, Adams RN, Palardy GR, Johnson MM, McFarland HI, Recher M, Drachman DB, Lenardo MJ.

Eur J Immunol. 2002 Jul;32(7):2055-67.

6.
7.

Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis.

Yang H, Kala M, Scott BG, Goluszko E, Chapman HA, Christadoss P.

J Immunol. 2005 Feb 1;174(3):1729-37.

8.

Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.

Duan RS, Adikari SB, Huang YM, Link H, Xiao BG.

Neurobiol Dis. 2004 Jul;16(2):461-7.

PMID:
15193302
10.

Experimental autoimmune myasthenia gravis in mice expressing human immunoglobulin loci.

Stassen MH, Meng F, Melgert E, Machiels BM, Im SH, Fuchs S, Gerritsen AF, van Dijk MA, van de Winkel JG, De Baets MH.

J Neuroimmunol. 2003 Feb;135(1-2):56-61.

PMID:
12576224
11.

Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.

Ostlie N, Milani M, Wang W, Okita D, Conti-Fine BM.

J Immunol. 2003 Jan 1;170(1):604-12.

12.

Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis.

Allman W, Saini SS, Tuzun E, Christadoss P.

Cell Immunol. 2011;271(2):292-8. doi: 10.1016/j.cellimm.2011.07.007. Epub 2011 Jul 28.

PMID:
21861992
13.

Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.

Yi HJ, Chae CS, So JS, Tzartos SJ, Souroujon MC, Fuchs S, Im SH.

Mol Immunol. 2008 Nov;46(1):192-201. doi: 10.1016/j.molimm.2008.08.264. Epub 2008 Sep 16.

PMID:
18799218
14.

Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.

Zhang GX, Xiao BG, Yu LY, van der Meide PH, Link H.

J Neuroimmunol. 2001 Feb 1;113(1):10-8.

PMID:
11137572
15.
16.

Experimental myasthenia gravis. A murine system.

Berman PW, Patrick J.

J Exp Med. 1980 Jan 1;151(1):204-23.

17.

Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis.

Tüzün E, Saini SS, Morgan BP, Christadoss P.

J Neuroimmunol. 2006 Dec;181(1-2):29-33. Epub 2006 Oct 23.

PMID:
17056125
18.

Immunological memory and late onset autoimmunity.

Stacy S, Krolick KA, Infante AJ, Kraig E.

Mech Ageing Dev. 2002 Apr 30;123(8):975-85. Review.

PMID:
12044946
19.

ACh receptor protein drives primary and memory autoantibody responses in chimeric human-SCID mice.

Yoshikawa H, Lennon VA.

Clin Immunol. 2002 Aug;104(2):128-37.

PMID:
12165274
20.

The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.

Xiao BG, Duan RS, Zhu WH, Lu CZ.

Cell Immunol. 2006 Jun;241(2):95-101. Epub 2006 Sep 26.

PMID:
17005165
Items per page

Supplemental Content

Write to the Help Desk